149 related articles for article (PubMed ID: 1702564)
1. Thiacetazone: in vitro activity against Mycobacterium avium and M. tuberculosis.
Heifets LB; Lindholm-Levy PJ; Flory M
Tubercle; 1990 Dec; 71(4):287-91. PubMed ID: 1702564
[TBL] [Abstract][Full Text] [Related]
2. Comparison of bacteriostatic and bactericidal activity of isoniazid and ethionamide against Mycobacterium avium and Mycobacterium tuberculosis.
Heifets LB; Lindholm-Levy PJ; Flory M
Am Rev Respir Dis; 1991 Feb; 143(2):268-70. PubMed ID: 1899326
[TBL] [Abstract][Full Text] [Related]
3. Bactericidal activity in vitro of various rifamycins against Mycobacterium avium and Mycobacterium tuberculosis.
Heifets LB; Lindholm-Levy PJ; Flory MA
Am Rev Respir Dis; 1990 Mar; 141(3):626-30. PubMed ID: 2155555
[TBL] [Abstract][Full Text] [Related]
4. Bacteriostatic and bactericidal activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.
Heifets LB; Lindholm-Levy PJ
Tubercle; 1987 Dec; 68(4):267-76. PubMed ID: 3138801
[TBL] [Abstract][Full Text] [Related]
5. MICs and MBCs of Win 57273 against Mycobacterium avium and M. tuberculosis.
Heifets LB; Lindholm-Levy PJ
Antimicrob Agents Chemother; 1990 May; 34(5):770-4. PubMed ID: 2113793
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of thiacetazone on mycobacterial species belonging to the Mycobacterium tuberculosis complex.
Abate G; Koivula T; Hoffner SE
Int J Tuberc Lung Dis; 2002 Oct; 6(10):933-5. PubMed ID: 12365582
[TBL] [Abstract][Full Text] [Related]
7. Ethambutol MICs and MBCs for Mycobacterium avium complex and Mycobacterium tuberculosis.
Heifets LB; Iseman MD; Lindholm-Levy PJ
Antimicrob Agents Chemother; 1986 Dec; 30(6):927-32. PubMed ID: 3101588
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro-piperidyl rifamycin.
Woodley CL; Kilburn JO
Am Rev Respir Dis; 1982 Sep; 126(3):586-7. PubMed ID: 6289711
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium, and rifampin against M. tuberculosis in cultured human macrophages.
Crowle AJ; Elkins N; May MH
Am Rev Respir Dis; 1988 May; 137(5):1141-6. PubMed ID: 3143278
[TBL] [Abstract][Full Text] [Related]
10. Comparison of bactericidal activities of streptomycin, amikacin, kanamycin, and capreomycin against Mycobacterium avium and M. tuberculosis.
Heifets L; Lindholm-Levy P
Antimicrob Agents Chemother; 1989 Aug; 33(8):1298-301. PubMed ID: 2478073
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of 12 antimicrobial peptides against Mycobacterium tuberculosis and Mycobacterium avium clinical isolates.
Portell-Buj E; Vergara A; Alejo I; López-Gavín A; Monté MR; San Nicolás L; González-Martín J; Tudó G
J Med Microbiol; 2019 Feb; 68(2):211-215. PubMed ID: 30570475
[TBL] [Abstract][Full Text] [Related]
12. In vitro activities of 2,2'-bipyridyl analogues against Mycobacterium avium and M. tuberculosis.
Dhople AM; Dhople AA; Ibanez MA
Tuber Lung Dis; 1995 Apr; 76(2):136-40. PubMed ID: 7780096
[TBL] [Abstract][Full Text] [Related]
13. Antituberculosis agents. IX. In vitro antimycobacterial activity of N-(2-phenyl-2-oxoethyl) and N-[2-(4-fluorophenyl)-2-oxoethyl]ciprofloxacin derivatives against some drug-resistant strains of Mycobacterium tuberculosis and Mycobacterium avium isolates.
Foroumadi A; Soltani F
Boll Chim Farm; 2003; 142(6):248-50. PubMed ID: 14606264
[TBL] [Abstract][Full Text] [Related]
14. In-vitro bacteriostatic and bactericidal activity of isoniazid on the Mycobacterium avium-Mycobacterium intracellulare complex.
Tsukamura M
Tubercle; 1990 Sep; 71(3):199-204. PubMed ID: 2238126
[TBL] [Abstract][Full Text] [Related]
15. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T
J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635
[TBL] [Abstract][Full Text] [Related]
16. Bacteriostatic and bactericidal activities of benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis and Mycobacterium avium in human macrophages.
Mor N; Simon B; Heifets L
Antimicrob Agents Chemother; 1996 Jun; 40(6):1482-5. PubMed ID: 8726023
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibilities of mycobacteria as determined by differential light scattering and correlation with results from multiple reference laboratories.
Conville PS; Witebsky FG; MacLowry JD
J Clin Microbiol; 1994 Jun; 32(6):1554-9. PubMed ID: 8077403
[TBL] [Abstract][Full Text] [Related]
18. Determination of in vitro susceptibility of mycobacteria to ansamycin.
Heifets LB; Iseman MD
Am Rev Respir Dis; 1985 Sep; 132(3):710-1. PubMed ID: 3929660
[TBL] [Abstract][Full Text] [Related]
19. Antimycobacterial activity of 1-deaza-7,8-dihydropteridine derivatives against Mycobacterium tuberculosis and Mycobacterium avium complex in vitro.
Suling WJ; Maddry JA
J Antimicrob Chemother; 2001 Apr; 47(4):451-4. PubMed ID: 11266419
[TBL] [Abstract][Full Text] [Related]
20. In Vitro Activity of 3-Triazeneindoles against Mycobacterium tuberculosis and Mycobacterium avium.
Nikonenko BV; Kornienko A; Majorov K; Ivanov P; Kondratieva T; Korotetskaya M; Apt AS; Salina E; Velezheva V
Antimicrob Agents Chemother; 2016 Oct; 60(10):6422-4. PubMed ID: 27503657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
